Strata Critical Medical Files 8-K/A Amendment
Ticker: SRTAW · Form: 8-K/A · Filed: Dec 2, 2025 · CIK: 1779128
| Field | Detail |
|---|---|
| Company | Strata Critical Medical, Inc. (SRTAW) |
| Form Type | 8-K/A |
| Filed Date | Dec 2, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, acquisition, disposition, financial-statements
TL;DR
Strata Critical Medical filed an amendment to its 8-K, updating asset acquisition/disposition details.
AI Summary
Strata Critical Medical, Inc. filed an amendment (8-K/A) on December 2, 2025, regarding an event that occurred on September 16, 2025. This filing pertains to the completion of an acquisition or disposition of assets and includes financial statements and exhibits. The company was formerly known as Blade Air Mobility, Inc. and Experience Investment Corp.
Why It Matters
This amendment provides updated information and exhibits related to a significant corporate event, such as an acquisition or disposition of assets, which could impact the company's structure and financial standing.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and does not introduce new material events or financial distress.
Key Players & Entities
- Strata Critical Medical, Inc. (company) — Registrant
- Blade Air Mobility, Inc. (company) — Former Company Name
- Experience Investment Corp. (company) — Former Company Name
- 20251202 (date) — Filing Date
- 20250916 (date) — Event Date
FAQ
What is the primary purpose of this 8-K/A filing?
The primary purpose of this 8-K/A filing is to amend a previous report and provide information regarding the completion of an acquisition or disposition of assets, along with accompanying financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on September 16, 2025.
What were the previous names of Strata Critical Medical, Inc.?
Strata Critical Medical, Inc. was formerly known as Blade Air Mobility, Inc. and Experience Investment Corp.
What is the filing date of this amendment?
This amendment was filed as of December 2, 2025.
What type of information is included in this filing besides the event itself?
This filing includes financial statements and exhibits related to the completion of an acquisition or disposition of assets.
Filing Stats: 1,043 words · 4 min read · ~3 pages · Grade level 10 · Accepted 2025-12-02 15:14:34
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SRTA The Nasdaq Stock Market
- $11.50 — one share of Common Stock at a price of $11.50 SRTAW The Nasdaq Stock Market Indicat
Filing Documents
- srta-20250916.htm (8-K/A) — 38KB
- consenttoksaudited2024.htm (EX-23.1) — 2KB
- exhibit991-kpsauditedfinan.htm (EX-99.1) — 177KB
- exhibit992-kpsinterimunaud.htm (EX-99.2) — 243KB
- exhibit993proformastratawi.htm (EX-99.3) — 263KB
- image_0.jpg (GRAPHIC) — 0KB
- 0001628280-25-054709.txt ( ) — 952KB
- srta-20250916.xsd (EX-101.SCH) — 2KB
- srta-20250916_def.xml (EX-101.DEF) — 16KB
- srta-20250916_lab.xml (EX-101.LAB) — 27KB
- srta-20250916_pre.xml (EX-101.PRE) — 16KB
- srta-20250916_htm.xml (XML) — 4KB
01 Completion of Acquisition or Disposition of Assets
Item 2.01 Completion of Acquisition or Disposition of Assets The information set forth in the "Explanatory Note" of this Amendment is incorporated by reference into this Item 2.01.
01 - Financial Statements and Exhibits
Item 9.01 - Financial Statements and Exhibits (a) Financial statements of business acquired. The audited consolidated financial statements of Keystone Perfusion Services P.C. as of December 31, 2024 and for the year then ended and the accompanying notes thereto, are incorporated by reference as Exhibit 99.1 hereto. The financial statements presented relate to Keystone Perfusion Services, P.C. ("Keystone P.C."), the historical operating entity. Immediately prior to the closing of the Acquisition, Keystone P.C. completed a reorganization and conversion in which Keystone P.C. was converted into Keystone. Keystone succeeded to all of the assets, liabilities, and operations of Keystone P.C. and became the "Target Company" acquired by the Company pursuant to the Purchase and Sale Agreement dated September 16, 2025. As a result, the historical financial statements presented for Keystone P.C. represent the predecessor operations of the acquired business. The unaudited condensed consolidated financial statements of Keystone P.C. as of June 30, 2025 and 2024 and for the three and six months then ended and the accompanying notes thereto, are incorporated by reference as Exhibit 99.2 hereto. (b) Pro forma financial information. The following unaudited pro forma financial information of the Company is filed as Exhibit 99.3 and is incorporated herein by reference: 1. Unaudited Pro Forma Condensed Combined Statement of Operations for the years ended December 31, 2024 and December 31, 2023 and the nine months ended September 30, 2025. 2. Notes to the Unaudited Pro Forma Condensed Combined Financial Statements. (d) The following exhibits are being filed herewith: Exhibit No. Description 23.1 Consent of Deloitte & Touche LLP 99.1 The audited consolidated financial statements of Keystone Perfusion Services P.C. as of and for the year ended December 31, 2024 and the related notes. 99.2 The unaudited condensed consolidated financial statements of Keystone Perfusion